Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

Artificial intelligence (AI) in drug development

AI in oncology: Current clinical endeavors and future directions

Date

05 Mar 2025

Session

Artificial intelligence (AI) in drug development

Topics

Cancer Diagnostics;  Staging and Imaging;  Therapy;  Cancer Research

Tumour Site

Presenters

Jakob Nikolas Kather

Authors

J.N.N. Kather

Author affiliations

  • Medical Oncology Department, Technische Universität Dresden - Carl Gustav Carus Faculty of Medicine, 01307 - Dresden/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Artificial intelligence (AI) in drug development

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.